v3.26.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Investments:    
Equity securities, at fair value (cost: $0 and $1,532) $ 113
Cash and cash equivalents 268 2,135
Restricted cash and cash equivalents 6,708 3,758
Premiums receivable 766 1,059
Other investments 48
Deferred policy acquisition costs 102 109
Operating lease right-of-use assets 43 148
Prepayment and other assets 150 94
Property and equipment, net 16 1
Total assets 8,053 7,465
Liabilities:    
Reserve for losses and loss adjustment expenses 91
Notes payable to noteholders 118 118
Unearned premiums reserve 926 991
Losses Payable 73
Operating lease liabilities 43 148
Accounts payable and other liabilities 309 366
Total liabilities 1,560 1,623
Mezzanine Equity    
Due to EpsilonCat Re / DeltaCat Re / EtaCat Re / ZetaCat Re Tokenholders 518 1,732
Shareholders’ equity:    
Ordinary share capital, (par value $0.001, 500,000,000 shares authorized; 7,664,122 and 6,379,002 shares issued and outstanding) 6 6
Additional paid-in capital 38,047 34,105
Accumulated Deficit (32,137) (30,163)
Total Oxbridge shareholders’ equity 5,916 3,948
Non-controlling interests 59 162
Total shareholders’ equity 5,975 4,110
Total liabilities, mezzanine and shareholders’ equity $ 8,053 $ 7,465